| Company Name: |
DC Chemicals |
| Tel: |
021-58447131 13564518121 |
| Email: |
doncunbiosci@gmail.com |
|
| | 2,4-Quinazolinediamine, N2-[(4-chloro-2-methoxyphenyl)methyl]-N4-(5-ethyl-1H-pyrazol-3-yl)-5-methoxy- Basic information |
| | 2,4-Quinazolinediamine, N2-[(4-chloro-2-methoxyphenyl)methyl]-N4-(5-ethyl-1H-pyrazol-3-yl)-5-methoxy- Chemical Properties |
| Boiling point | 679.5±65.0 °C(Predicted) | | density | 1.369±0.06 g/cm3(Predicted) | | pka | 14.07±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | 2,4-Quinazolinediamine, N2-[(4-chloro-2-methoxyphenyl)methyl]-N4-(5-ethyl-1H-pyrazol-3-yl)-5-methoxy- Usage And Synthesis |
| Uses | GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with an IC50 of 120 nM. GRK6 is a critical kinase required for the survival of multiple myeloma (MM) cells. GRK6-IN-1 has the potential for the research of multiple myeloma[1]. | | References | [1] Uehling DE, et al. Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma [published correction appears in J Med Chem. 2022 Jan 13;65(1):886-887]. J Med Chem. 2021;64(15):11129-11147. DOI:10.1021/acs.jmedchem.1c00506 |
| | 2,4-Quinazolinediamine, N2-[(4-chloro-2-methoxyphenyl)methyl]-N4-(5-ethyl-1H-pyrazol-3-yl)-5-methoxy- Preparation Products And Raw materials |
|